VAXELIS 20 ug/.5mL
diphtheria and tetanus toxoids and acellular pertussis, inactivated poliovirus, haemophilus b conjugate and hepatitis b vaccine · INJECTION, SUSPENSION · A-S Medication Solutions
VAXELIS is a injection, suspension containing diphtheria and tetanus toxoids and acellular pertussis, inactivated poliovirus, haemophilus b conjugate and hepatitis b vaccine at 20 ug/.5mL, taken intramuscular. Manufactured by A-S Medication Solutions.
Key Facts
- Brand Name
- VAXELIS
- Generic Name
- diphtheria and tetanus toxoids and acellular pertussis, inactivated poliovirus, haemophilus b conjugate and hepatitis b vaccine
- NDC Code (Product)
50090-7542- Manufacturer
- A-S Medication Solutions
- Strength
- 20 ug/.5mL
- Dosage Form
- INJECTION, SUSPENSION
- Route
- INTRAMUSCULAR
- Marketing Status
- Application #
- BLA125563
- Marketing Start
- 12/21/2018
Recall History
No Recall HistoryFrequently Asked Questions
What is VAXELIS used for?
VAXELIS contains diphtheria and tetanus toxoids and acellular pertussis, inactivated poliovirus, haemophilus b conjugate and hepatitis b vaccine. It is a injection, suspension taken intramuscular. Consult your doctor for specific uses.
Is VAXELIS a controlled substance?
VAXELIS is not classified as a controlled substance by the DEA.
What is the generic name for VAXELIS?
The generic name for VAXELIS is diphtheria and tetanus toxoids and acellular pertussis, inactivated poliovirus, haemophilus b conjugate and hepatitis b vaccine. There are no other listed brand versions of diphtheria and tetanus toxoids and acellular pertussis, inactivated poliovirus, haemophilus b conjugate and hepatitis b vaccine.
What is the NDC code for VAXELIS 20 ug/.5mL?
The NDC (National Drug Code) for VAXELIS 20 ug/.5mL is 50090-7542, listed by A-S Medication Solutions.
Other VAXELIS Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)